Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #1

    Pacific Bio releases some details on SMRT Sequencer read lengths, library prep

    Our friends over at In Sequence posted a very interesting article containing details from Pacific Biosciences regarding their much anticipated third-gen uber-sequencer.

    I certainly don't want to steal their scoop so I won't go into detail here...I encourage you to visit their site as it's the first detailed look at what PB may offer as soon as 2010.

    Some points include long (Sanger-sized) or short reads, and five minute run times!

    UPDATED: In Sequence open access article here and above. Thanks to the editors at In Sequence for creating the open access link and for permission to repost.
  • bioinfosm
    Senior Member
    • Jan 2008
    • 483

    #2
    In sequence subscription is the issue
    --
    bioinfosm

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      I know. I'm not sure I feel right about posting info that is their site's core value.

      Plus they are very nice people. Perhaps I'll write a summary later today.

      EDIT: Just updated the first post with an open-access link to the article. Thanks to the editors of In Sequence for creating the link and permission to post.

      Comment

      • bioinfosm
        Senior Member
        • Jan 2008
        • 483

        #4
        good job Eco!

        Other articles possible as well *greedy me*
        --
        bioinfosm

        Comment

        • apfejes
          Senior Member
          • Feb 2008
          • 236

          #5
          I spent half the morning running around trying to find someone with a subscription... Thanks to In Sequence for allowing this article to be released as open access, and thanks for posting the link, ECO!
          The more you know, the more you know you don't know. —Aristotle

          Comment

          • ECO
            --Site Admin--
            • Oct 2007
            • 1360

            #6
            Originally posted by bioinfosm View Post
            good job Eco!

            Other articles possible as well *greedy me*
            Originally posted by apfejes View Post
            I spent half the morning running around trying to find someone with a subscription... Thanks to In Sequence for allowing this article to be released as open access, and thanks for posting the link, ECO!
            Believe it or not, In Sequence is open access to education users. The editor told me the process is currently a bit clunky and they are working on that, but it's definitely possible now.

            Comment

            • apfejes
              Senior Member
              • Feb 2008
              • 236

              #7
              Heh... I guess I should have spent more time trying to navigate their site than to find someone who already had access. Old habits die hard, I suppose.

              One more publication to add to the reading list, then!
              The more you know, the more you know you don't know. —Aristotle

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 08-06-2026, 07:41 AM
              0 responses
              23 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 08-03-2026, 10:13 AM
              0 responses
              37 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              43 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              26 views
              0 reactions
              Last Post SEQadmin2  
              Working...